(Q56971567)
Statements
The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel (English)
0 references
March 2013
0 references
704
0 references
1-3
0 references
15-22
0 references